0.47
3.21%
0.0146
Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie
Cadrenal drug moving closer to FDA approval | Jax Daily Record - Jacksonville Daily Record
Jacksonville Daily Record
Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 - StockTitan
StockTitan
Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 - StockTitan
StockTitan
HC Wainwright Research Analysts Reduce Earnings Estimates for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) - Defense World
Defense World
Cadrenal Therapeutics' (CVKD) Buy Rating Reaffirmed at HC Wainwright - Defense World
Defense World
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance ... - PR Newswire
PR Newswire
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance ... - PR Newswire
PR Newswire
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - PR Newswire
PR Newswire
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - PR Newswire
PR Newswire
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - Longview News-Journal
Longview News-Journal
Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St
Simply Wall St
Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St
Simply Wall St
Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St
Simply Wall St
Cadrenal Therapeutics (NASDAQ:CVKD) Earns Buy Rating from HC Wainwright - Defense World
Defense World
Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - PR Newswire
PR Newswire
Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - PR Newswire
PR Newswire
Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock - Yahoo Finance UK
Yahoo Finance UK
Analyzing Cadrenal Therapeutics (CVKD) & Its Peers - Defense World
Defense World
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
InvestorPlace
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin - TipRanks
TipRanks
Cadrenal Therapeutics Gets FDA Orphan Drug Designation for Tecarfarin - MarketWatch
MarketWatch
Zura Bio Names Robert Lisicki as CEO & Director of the Board - Contract Pharma
Contract Pharma
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace
InvestorPlace
Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update - PR Newswire
PR Newswire
Iambic hires Josephson as CMO - BioCentury
BioCentury
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial - PR Newswire
PR Newswire
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation ... - PR Newswire
PR Newswire
Here's Why We're Not Too Worried About Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation - Yahoo Finance
Yahoo Finance
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Benzinga
Thinking about buying stock in KE Holdings, Ford Motor, Vertiv Holdings, Cadrenal Therapeutics, or Aclaris ... - Marketscreener.com
Marketscreener.com
Thinking about buying stock in KE Holdings, Ford Motor, Vertiv Holdings, Cadrenal Therapeutics, or Aclaris ... - Marketscreener.com
Marketscreener.com
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
InvestorPlace
Cadrenal Therapeutics to Present at the Biotech Showcase on January 8, 2024 Alongside the J.P. Morgan Annual ... - PR Newswire
PR Newswire
Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target - PR Newswire
PR Newswire
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day ... - Markets Insider
Markets Insider
Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and ... - PR Newswire
PR Newswire
Biopharma IPO class of 2023: Performance down 27% - BioWorld Online
BioWorld Online
Health Care Innovators: Cadrenal Therapeutics works to prevent heart attacks | Jax Daily Record - Jacksonville Daily Record
Jacksonville Daily Record
Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from ... - PR Newswire
PR Newswire
Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS) - PR Newswire
PR Newswire
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
Cadrenal Therapeutics Announces Closing of $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - PR Newswire
PR Newswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):